Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1901-2024Class II

smith&nephew OXINIUM Femoral Head 12/14 Taper, REF 71343204, 32 MM OD +4, Sterile; and smith&nephew, 12/14...

Smith & Nephew, Inc. / initiated 2024-04-24 / Open, Classified / root cause: manufacturing process

Smith & Nephew Inc began a recall of smith&nephew OXINIUM Femoral Head 12/14 Taper, REF 71343204, 32 MM OD +4, Sterile; and smith&nephew, 12/14 Taper, REF 71343604, 36 MM M / +4 on . FDA classified it as Class II and gives the reason as "Packaging contained the incorrect size of femoral head from what was displayed on the label". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1901-2024
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Smith & Nephew, Inc.
Product
smith&nephew OXINIUM Femoral Head 12/14 Taper, REF 71343204, 32 MM OD +4, Sterile; and smith&nephew, 12/14 Taper, REF 71343604, 36 MM M / +4
Product code
LZO Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented
Reason for recall
Packaging contained the incorrect size of femoral head from what was displayed on the label.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
The recalling firm issued letters on 4/24/2024 informing the consignees of the issue, the patient impact, risks to health, and the actions to be taken by the users. The actions included to locate and quarantine affected devices immediately and if they have been further distributed to other organizations, the consignee is requested to inform their consignees of this field action and provide a copy of the letter. A Customer Response form is to be completed and emailed or FAX'd back to the national Smith + Nephew agency/distributor. The product is to be returned to the national Smith + Nephew agency/distributor.
Quantity in commerce
23 packages
Distribution
International distribution to the countries of Australia, Germany, Japan, Portugal, and United Kingdom.
Product codes and lots
REF 71343204 - Batch #23FM03219, Exp. June 2033; REF 71343604 - Batch 23FM04184, Exp. June 2033.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1901-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1901-2024Class IIOngoingVoluntary: Firm initiated